Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Australian Stock Exchange  >  ALS Limited    ALQ   AU000000ALQ6

ALS LIMITED

(ALQ)
  Report
End-of-day quote. End-of-day quote Australian Stock Exchange - 01/15
10.07 AUD   +1.51%
2020ALS LIMITED : Ex-dividend day for interim dividend
FA
2020ALS : To Benefit As Mineral Exploration Heats Up
AQ
2020ALS Posts Downbeat Fiscal H1 Net Profit; Shares Fall 3%
MT
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Financials
Sales 2021 1 764 M 1 359 M 1 359 M
Net income 2021 176 M 136 M 136 M
Net Debt 2021 788 M 607 M 607 M
P/E ratio 2021 27,6x
Yield 2021 1,88%
Sales 2022 1 913 M 1 473 M 1 473 M
Net income 2022 220 M 169 M 169 M
Net Debt 2022 724 M 558 M 558 M
P/E ratio 2022 22,2x
Yield 2022 2,41%
Capitalization 4 857 M 3 749 M 3 741 M
EV / Sales 2021 3,20x
EV / Sales 2022 2,92x
Nbr of Employees -
Free-Float 97,3%
More Financials
Company
ALS Limited is a testing services provider. The principal activities of the Company are the provision of professional technical services in the areas of testing, measurement, inspection and monitoring; food and pharmaceutical quality assurance; mining and mineral exploration; commodity certification; equipment maintenance, and asset care operations. The Company's segments include: ALS Life Sciences, which provides... 
Sector
Business Support Services
Calendar
-
More about the company
Notations Surperformance© of ALS Limited
Trading Rating : Investor Rating :
More Ratings
All news about ALS LIMITED
2020ALS LIMITED : Ex-dividend day for interim dividend
FA
2020ALS : To Benefit As Mineral Exploration Heats Up
AQ
2020ALS Posts Downbeat Fiscal H1 Net Profit; Shares Fall 3%
MT
2020ALS LIMITED : half-yearly earnings release
2020Denali Down 10% After Hours on Pause in DNL747 Studies
DJ
2020NEWS HIGHLIGHTS : Top Company News of the Day
DJ
2020ALS LIMITED : Ex-dividend day for final dividend
FA
2020NEWS HIGHLIGHTS : Top Company News of the Day
DJ
2020JEFF BEZOS : Top Company News of the Day
DJ
2020Health Care Down As Analysts See Rally Overstretched -- Health Care Roundup
DJ
2020ALS : Korea Midland power bans Australian lab ALS; police assess probe
RE
2020ALS : Poised For Recovery
AQ
2020ALS LIMITED : annual earnings release
2020Korea South East Power Co bans Australian testing lab from coal tenders
RE
2019Japan's Astellas to buy Audentes for $3 billion in high-priced gene therapy b..
RE
More news
News in other languages on ALS LIMITED
2020ALS LIMITED : Veröffentlichung des Halbjahresergebnisses
2020ALS LIMITED : publication des résultats semestriels
2020IPO : Ina Invest Holding mit erfolgreichem Start an der Börse
2020AXOVANT GENE THERAPIES LTD. : Veröffentlichung des Jahresergebnisses
2020HUDSON LTD. : Veröffentlichung des Quartalsergebnisses
More news
Analyst Recommendations on ALS LIMITED
More recommendations
Chart ALS LIMITED
Duration : Period :
ALS Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALS LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 9,80 AUD
Last Close Price 10,07 AUD
Spread / Highest target 9,24%
Spread / Average Target -2,70%
Spread / Lowest Target -45,4%
EPS Revisions
Managers and Directors
NameTitle
Raj Naran Chief Executive Officer, MD & Director
Bruce John Phillips Chairman
Luis Damasceno Chief Financial Officer
John Francis Mulcahy Independent Non-Executive Director
Charlie B. Sartain Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
ALS LIMITED4.79%3 749
CINTAS CORPORATION-7.75%34 247
TELEPERFORMANCE4.24%20 080
UNITED RENTALS10.02%18 405
LG CORP.21.14%16 789
EDENRED0.30%13 835